In a landmark move poised to reshape Alzheimer's disease management for millions, China has formally included the innovative treatment Leqembi (lecanemab) in its newly established "Commercial Insurance Innovative Drug List." This strategic decision, announced by BioArctic's partner Eisai,
A Market's Soul on Trial The Lloyd’s of London insurance market, an institution steeped in centuries of tradition and defined by its global influence, is once again facing a profound identity crisis that strikes at the very heart of its corporate character. The decision to reopen an investigation
In an era where digital presence is synonymous with business survival, a deeply concerning paradox has emerged for the United Kingdom's small and medium-sized enterprises, with data revealing that a staggering majority have suffered a cyber incident yet remain critically under-protected. This
A landmark decision from the North Carolina Court of Appeals has sent a powerful message regarding judicial oversight in complex financial cases, affirming a lower court's civil contempt order against financier Greg Lindberg and his company, Global Growth. The appellate court's ruling on December
We're joined today by Simon Glairy, a leading expert in risk management and insurance law, to dissect a recent Delaware Supreme Court decision with significant implications for workers' compensation. The case of a Wilmington firefighter, Corey Ferrell, brings into sharp focus the complex interplay
The delegated authority broking model that once defined the industry is no longer viable, as the ground has irrevocably shifted beneath it. With delegated business now accounting for approximately 45% of Lloyd's of London's total premium and on a trajectory to become the dominant majority, the
